Jonathan J Stillo
@jonathanjstillo
Followers
1K
Following
6K
Media
97
Statuses
1K
Medical anthropologist, Associate Professor at Wayne State University. Loves Romania, hates TB, passionate about global health & human rights. Views are my own.
Detroit, MI
Joined December 2011
Should we still do #DOT for #TB? My article is now out in Human Organization. Here is the open access link: https://t.co/5lkApKczj4 (thanks to @WayneStateCLAS @AnthroAtWayne & @waynestate OVPR for support) @SfAAnthro @sshiftb @TBECoalition @StopTBUSA @TAGTeam_Tweets @StopTB
2
12
19
Happening right now: Highlights from NAR – Reframing Directly Observed Treatment Wednesday, May 7th, 2025 10:30 am - 1:00 pm (Pacific Time) (1:30-4:00pm Eastern Time) https://t.co/MUq0tpRMCz
#tb @StopTBUSA @TBFighters @realTBpeople @TBECoalition
ucsf.zoom.us
Zoom is the leader in modern enterprise cloud communications.
0
1
2
Highlights from NAR – Reframing Directly Observed Treatment Wednesday, May 7th, 2025 10:30 am - 1:00 pm (Pacific Time) (1:30-4:00pm Eastern Time) Registration Deadline: Tuesday, May 6th, 2025 Register here: https://t.co/O2QUuL2oY3
@StopTB #tb @TheUnion_TBLH @realTBpeople
0
0
0
"Our public health infrastructure is fragile, understaffed and under-resourced,” Stillo said. And public health infrastructure is key to preventing TB-related disaster." @StopTBUSA @TAGTeam_Tweets @AnthroAtWayne @We_Are_TB @WayneStateCLAS
https://t.co/4JZlvJ4jmF
salon.com
Slashes in federal funding for disease surveillance could once more make old diseases formidable foes
0
3
4
Note our TIME CHANGE! Our Annual Membership Meeting will happen on Friday, February 28th at 5:00pm Pacific and 8:00pm Eastern Time. We can't wait to see you there!! #endtb #stoptb #stoptbnow
0
1
1
The deadline for collection of candidate's applications for joining the TBEC Board is extended till 26th December 2024! More information ➡️ https://t.co/jaVYbE74Xu
0
4
6
XDR #TB is a #GlobalHealth emergency. Clinicians, affected community, and other experts have come together to create a field guide for managing TB with expanded resistance. Please share widely. @TAGTeam_Tweets @TBECoalition @StopTBUSA
0
3
6
Delamanid is now part of WHO-recommended short-course DR-TB regimens, so access is more urgent than ever. Recent price ⬇️ is good step, but doesn't go far enough! We've fought for delamanid access for years (see pics!) + will continue. 1/4/6x24 statement: https://t.co/OTTiD4SzuL
0
4
11
MSF Calls for Equitable Access to TB Drugs and Diagnostics in First-Ever Plenary Session on Access at the TB Union Conference https://t.co/ZnLqF1L2d3
globaltbcab.org
This is the first ever time a plenary session at the ‘Union Conference’ was devoted to access to medical tools.
0
10
18
People w/ extensively drug-resistant TB have the fewest treatment options. Addressing their needs reimagining pre-approval access mechanisms, urges a growing consensus of researchers + TB survivors. New statement from the TB CAB: https://t.co/aJFd1H7cj9
0
7
12
Amazing findings! Debrah Vambe sharing findings @UnionConference from Eswatini highlights profound gaps in existing diagnostic algorithms that potentially miss Bdq resistance (and clofazimine) among diagnosed INH-or MDRTB-resistant! This data is from 2021-2022!!
1
2
7
Critical insights being shared right now by Paran - a TB survivor and brilliant speaker @UnionConference! She asks us all: We don’t have longer regimens, and no injectables for a majority of #MDRTB patients … but what is our plan B if the shorter regimens fail?
0
2
7
For future medical tools, we want countries and donors to start attaching access requirements to public funding that is given for R&D. Only then can we guarantee access and affordability of tests and treatments. @Christo51566018 #UnionConf2024 @MSF_access
https://t.co/anezzJH0e5
msfaccess.org
TB champions, associations and civil society have been playing a pivotal role in pushing back against patent monopolies and high prices that, for more than a decade, have kept newer and safer TB...
1
11
14
A message for Pharmaceutical Corporations Otsuka and Viatris- Make Delamanid Affordable Now! Price of this drug still remains high at $1100 by Otsuka and $800 by Viatris. If we really want to see wider scale up and save lives of people, price need to go down.
1
15
20
Let us share with you a publication "Building social equity and person-centred innovation into the end TB response" - https://t.co/wlKrM3WeRd, which addresses a social science perspective on equity and the TB response.
0
1
3
"60% of LICs and 25% of MICs are in debt stress, 3.3 B people live in countries that spend more on interest payments than on education or health. Urgent #debtrelief and restructuring is needed to free up fiscal space for health." - @doctorsoumya @UnionConference
#Unionconf2024
1
9
15
More than 70 TB activists from around the world called on @DanaherCorp and @CepheidNews at the @UnionConference to make all GeneXpert cartridges affordable for all and also to open their books and share the audit.
3
30
59
THE BETTER TB project’s statement on pre approval access https://t.co/gGtUWtZNQE please read and share. @TBECoalition @StopTBUSA @TAGTeam_Tweets #TB #AMR
dropbox.com
Shared with Dropbox
0
2
2
5⃣ means by which a social science lens can strengthen equitable, person-centred responses + reconcile the public health significance of TB with the principles of social justice https://t.co/ThRktAIPMc
sshiftb.org
Reducing systemic inequities in testing, access to care, social protection – and in the scientific process – is essential to end TB. Incorporating social science methods and expertise on inequity...
1
5
4